Frazier Life Sciences Management, L.P. - NABRIVA THERAPEUTICS PLC ownership

Back to all holdings Add to watchlist

NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637139. A total of 13 filers reported holding NABRIVA THERAPEUTICS PLC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
Frazier Life Sciences Management, L.P. ownership history of NABRIVA THERAPEUTICS PLC
ValueSharesWeighting
Q1 2023$29,741
-7.6%
17,0250.0%0.00%0.0%
Q4 2022$32,177
-8.1%
17,0250.0%0.00%
-33.3%
Q3 2022$35,000–17,025–0.00%–
 Download
Other shareholders

There were no reported owners of NABRIVA THERAPEUTICS PLC in Q1 2023.

NameSharesValueWeighting ↓
View complete list of NABRIVA THERAPEUTICS PLC shareholders